COX-2 inhibition is suggested to aid as an adjunctive to antiepileptic drug therapy due to the potential to prevent an upregulation of the multidrug transporter P-glycoprotein, which is often overexpressed in drug-resistant epilepsy [68]. The gene discussed is ABCB1; the disease is epilepsy.